Radiotherapeutic efficacy of 153Sm-CMDTPA-Tyr3-octreotate in tumor-bearing rats☆

This publication has 20 references indexed in Scilit:

• Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumours
  Nuclear Medicine Communications, 2000
• Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amount
  European Journal of Nuclear Medicine and Molecular Imaging, 1999
• In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. a new somatostatin analog with improved target tissue uptake
  Nuclear Medicine and Biology, 1999
• Renal Metabolism of ¹¹¹In-DTPA-d-Phe¹-Octreotide in Vivo
  Bioconjugate Chemistry, 1998
• Somatostatin receptor scintigraphy using [ 111 In-DTPA 0 ]RC-160 in humans: a comparison with [ 111 In-DTPA 0 ]octreotide
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in rats
  Nuclear Medicine and Biology, 1997
• Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy
  European Journal of Nuclear Medicine and Molecular Imaging, 1997
• Evaluation in vitro and in rats of161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• Radiation synovectomy revisited
  European Journal of Nuclear Medicine and Molecular Imaging, 1993
• Transplantation of azaserine-induced carcinomas of pancreas in rats
  Cancer Letters, 1979